ClinicalTrials.Veeva

Menu

The Stroke Vision App: A Screening Tool for Visual Stroke

NHS Trust logo

NHS Trust

Status

Unknown

Conditions

Stroke
Eye Abnormalities

Treatments

Procedure: Visual field assessment to confrontation
Procedure: Formal Perimetry (Goldman or Octopus visual Field)
Device: Digital shape cancellation assessment
Procedure: Visual inattention assessment to bilateral stimuli
Device: Digital tumbling E visual accuity assessment
Procedure: Albert's visual inattention test
Device: Digital line crossing assessment
Procedure: Star cancellation visual inattention test
Device: Digital visual field assessment

Study type

Interventional

Funder types

Other

Identifiers

NCT02539381
GN15NE064

Details and patient eligibility

About

Visual impairment can affect up to 70% of stroke survivors, but many do not have their vision adequately assessed in hospital. An unidentified visual defect can cause significant problems for recovery and quality of life. The Stroke Vision app (an application currently scaled for a 10" Android tablet) has been developed to act as a screening tool for visual problems in stroke survivors; to help identify visual problems earlier and thereby improve rehabilitation outcomes. The app includes a suite of tests for assessing the patient's acuity, their visual fields and to aid in the identification of visual neglect / inattention. Furthermore, it includes educational information on visual stroke in order to better educate staff, patients and their carers. This study seeks to validate the novel digital assessments included in the Stroke Vision app against the current methods used for screening (clinical examination by confrontation field testing). Both screening measures will be compared with the gold standard methods for visual assessments, Octopus perimetry for fields and paper-based methods for visuospatial neglect

Enrollment

62 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients referred to Visual Stroke Orthoptic Clinics
  • All patients with stroke or stroke-like visual problems (for example, but not limited to bitemporal hemianopia caused by pituitary adenoma) referred to the neuro-ophthalmology clinics.
  • Consent Provided

Exclusion criteria

  • No spoken English
  • Unable to provide consent
  • Profound cortical blindness

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

62 participants in 3 patient groups

Gold Standard Assessments
Other group
Description:
* Formal perimetry (Goldman or Octopus visual field) * Albert's visual inattention test * Star cancellation visual inattention test * line bisection test * These are performed as part of the routine assessment in the visual stroke orthoptic clinic and neuro-ophthalmology clinics. * The time to perform the assessments or if the participant is unable to complete the assessment will be recorded. * Researcher will record a score (0-10) to quantify the participant's compliance
Treatment:
Procedure: Star cancellation visual inattention test
Procedure: Albert's visual inattention test
Procedure: Formal Perimetry (Goldman or Octopus visual Field)
Usual Clinical Screening Practice
Other group
Description:
* Visual field assessment to confrontation * Visual inattention assessment to bilateral stimuli * The time to perform the assessments or if the participant is unable to complete the assessment will be recorded. * Researcher will record a score (0-10) to quantify the participant's compliance
Treatment:
Procedure: Visual field assessment to confrontation
Procedure: Visual inattention assessment to bilateral stimuli
Stroke Vision App
Other group
Description:
* Digital tumbling E visual accuity assessment * Digital visual field assessment * Digital line crossing assessment * Digital shape cancellation assessment * The time to perform the assessments or if the participant is unable to complete the assessment will be recorded. * Researcher will record a score (0-10) to quantify the participant's compliance
Treatment:
Device: Digital shape cancellation assessment
Device: Digital tumbling E visual accuity assessment
Device: Digital line crossing assessment
Device: Digital visual field assessment

Trial contacts and locations

1

Loading...

Central trial contact

Christine McAlpine, MBChB FRCP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems